However, H3 histone family member 3A (H3F3A) mutation is evidence of infiltrative glioma and an adverse prognostic marker before GBM establishment (Sturm et al., 2012; Meyronet et al., 2017). This evidence concerns the gene H3-3A and central nervous system cancer.